Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |